Moderna stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and ...
Share your thoughts and join the conversation in the comments.
Friday's edition of Forbes Daily covers Tesla's post-election rally losing steam, the fortune of AG pick Matt Gaetz, ...
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
US futures fell after Jerome Powell signaled the Federal Reserve was in no rush to cut interest rates, and unease built over the composition of President-elect Donald Trump’s cabinet.
Follow all the developments as Donald Trump continues to send rumbles through Washington D.C., with his cabinet picks.
When pharma’s R&D push peaked, hundreds of vaccines and treatments were in development to combat the novel coronavirus. And while the remobilization turned once-obscure biotechs like Moderna into ...
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...
Why It Matters: The appointment of Kennedy, a prominent critic of vaccines, as Health Secretary could signal a shift in ...
The news outlet is pushing the Commission to release text messages between the E.U.’s top official and Pfizer as they ...
Stock futures declined on Friday as Wall Street dialed back expectations for interest-rate cuts after Jerome Powell said the central bank wasn't in a hurry to reduce rates. Ten-year Treasury yields ...